Patents by Inventor Stephen FIACCO

Stephen FIACCO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating endometriosis
    Patent number: 11884749
    Abstract: Provided herein are peptides that bind ?-catenin, and compositions comprising said peptides. Peptides binding ?-catenin prevent translocation to the nucleus and modulate the canonical Wnt pathway. Also provided herein are methods of using said peptides and compositions in the treatment of tissue-infiltrating conditions including endometriosis.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: January 30, 2024
    Assignee: EndoMet Biosciences, Inc.
    Inventors: Tanya Petrossian, Stephen Fiacco, Tristin Rose, Amanda Hardy, Keerthi Boddupally, Matthew Willmore
  • COMPOSITIONS AND METHODS FOR TREATING ENDOMETRIOSIS
    Publication number: 20230121738
    Abstract: Provided herein are peptides that bind ?-catenin, and compositions comprising said peptides. Peptides binding ?-catenin prevent translocation to the nucleus and modulate the canonical Wnt pathway. Also provided herein are methods of using said peptides and compositions in the treatment of tissue-infiltrating conditions including endometriosis.
    Type: Application
    Filed: November 21, 2019
    Publication date: April 20, 2023
    Inventors: Tanya PETROSSIAN, Stephen FIACCO, Tristin ROSE, Amanda HARDY, Keerthi BODDUPALLY, Matthew WILLMORE
  • NOVEL COMPOUNDS ACTIVATING THE NRF2 PATHWAY
    Publication number: 20200255478
    Abstract: The invention relates to peptidic compounds, which peptidic compounds are compounds of formula (I)?, or a pharmaceutically acceptable salt, or solvate, or N-oxide, or stereoisomer thereof: wherein R1; R2; s; t; u; Aa78 and G1 are as defined herein. The peptidic compounds are useful in activating the Nrf2 pathway.
    Type: Application
    Filed: August 8, 2018
    Publication date: August 13, 2020
    Inventors: Carlos PUIG DURAN, Fernando ALBERICIO PALOMERA, Miriam GONGORA BENITEZ, Marta PARADIS BAS, Laia MIRET CASALS, Ivan RAMOS TOMILLERO, Stephen FIACCO, Andrew DAVIS, Stefan GESCHWINDNER, Omar BRUN CUBERO, Carlos HERAS PANIAGUA, Nuria TRALLERO CANELA
  • HER-2-SPECIFIC CYCLIZED SUPR PEPTIDES
    Publication number: 20180327453
    Abstract: Disclosed are highly potent peptides, peptide conjugates, host cells and compositions containing one or more of these peptides, peptide conjugates and/or host cells that are useful to inhibit the growth of a breast cancer cell or treat breast cancer in a patient in need of such treatment.
    Type: Application
    Filed: November 7, 2016
    Publication date: November 15, 2018
    Applicant: EVORX TECHNOLOGIES, INC.
    Inventors: Stephen FIACCO, Amanda HARDY